Revealing the regulatory mechanism of Astragaloside IV in treating chronic heart failure through network pharmacology and animal experiments
This study demonstrates that AS-IV delays the progression of CHF, which may be achieved by inhibiting myocardial apoptosis via activating the PI3K-AKT signaling pathway. These findings have laid the foundation for research and application of AS-IV in CHF treatment.
Authors
- Chaoqun Xing
- Xuemei Zhang
- Haichen Guan
- Xuanan Xiang
- Zhiyong Yao
Institutions
- Huaihua University (CN)
Publication Details
- Journal
- Revista Portuguesa de Cardiologia
- Published
- 2026-01-09
- DOI
- https://doi.org/10.1016/j.repc.2025.10.005
- Primary Topic
- Traditional Chinese Medicine Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00